Mann, Graham J <br/><br/>
BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma.  [electronic resource] 

 -  The Journal of investigative dermatology  Feb 2013 
 - 509-17 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-1747 
<br/><br/><label>Standard No.: </label>10.1038/jid.2012.283  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Databases, Factual--statistics & numerical data<br/>Female<br/>Genes, ras--genetics<br/>Genetic Testing--methods<br/>Humans<br/>Male<br/>Melanoma--genetics<br/>Middle Aged<br/>Neoplasm Staging<br/>Predictive Value of Tests<br/>Prognosis<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Reproducibility of Results<br/>Skin Neoplasms--genetics<br/>Transcriptome--immunology<br/>Treatment Outcome